Coinbase
COIN
Meta Platforms
META
Apple
AAPL
D.R. Horton
DHI
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
MACK Merrimack Pharmaceuticals
- 15.130
- 0.0000.00%
Trading May 17 16:00 ET
223.75MMarket Cap1.09P/E (TTM)
0.000High0.000Low0Volume0.000Open15.130Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)14.79MShares0.03152wk High1.01P/B146.21MFloat Cap0.02652wk Low--Dividend TTM9.66MShs Float0.130Historical High--Div YieldTTM0.00%Amplitude0.003Historical Low--Avg Price1Lot Size
Merrimack Pharmaceuticals Key Stats
EPS
According to the latest financial report of Merrimack Pharmaceuticals, the latest earnings per share (TTM) for the company is 13.93. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Merrimack Pharmaceuticals's free cash flow? The latest report shows it as -1.31M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Merrimack Pharmaceuticals shows that the company's current ratio is 10.78, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Merrimack Pharmaceuticals, the quick ratio is 10.77, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Merrimack Pharmaceuticals? The latest ROE figure is 167.53%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Merrimack Pharmaceuticals, the total asset return on investment (ROA) is 152.84%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Merrimack Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Merrimack Pharmaceuticals, the net profit margin is 70.85%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.